ArcticZymes Leverages Rising Interest in Salt-Active Nucleases with New Whitepaper on Advancing Viral Vector Manufacturing
ArcticZymes Leverages Rising Interest in Salt-Active Nucleases with New Whitepaper on Advancing Viral Vector Manufacturing
Notice of Annual General Meeting 2024
The annual general meeting (“AGM”) in ArcticZymes Technologies ASA will be held on Wednesday, June 26th, 2024, at 15.00 CET.
ArcticZymes Technologies Changes to the Board of Directors
Tromsø, Norway, May 13th, 2024—ArcticZymes Technologies (OSE: AZT) announces Nominations for new Board members and the resignations of the Chairman and a Board member.
Presentation of Q1 2024 Results
Tromsø, Norway, May 8th, 2024 – ArcticZymes Technologies (OSE: AZT) reported sales of NOK 30.0 million and an EBITDA of NOK 2.3 million for the first quarter of 2024.
Joint Research with Austrian Centre of Industrial Biotechnology
Tromsø, Norway, April 9, 2024 - ArcticZymes Technologies ASA (OSE: AZT) and the Austrian Centre of Industrial Biotechnology (acib) enter a joint research project to uncover the benefits of salt active nucleases in the purification of bionanoparticles (BNP’s).